# Application of Mixed Reality for Ophthalmic Clinical Skills and Diagnosis: Prospective Study

**Authors:** Chun Jin Marcus Tan, Wei Wei Dayna Yong, Hui'En Hazel Anne Lin, Jaslyn Oh, How Sheng Rubin Yong, Fang Mei Jayme Khew, Liang Shen, Yujia Gao, Wei Chieh Alfred Kow, Yih Chung Tham, Dianbo Liu, Ching-Yu Cheng, Kee Yuan Ngiam, Yew Sen Yuen, Ray Manotosh, Eng Tat Khoo, Teck Chang Victor Koh, Woon Teck Clement Tan

PMC · DOI: 10.2196/71338 · 2026-03-03

## TL;DR

A study found that using mixed reality with HoloLens 2 in ophthalmology education is as effective as traditional teaching and may offer additional benefits.

## Contribution

This study demonstrates that mixed reality can be a noninferior alternative to traditional clinical teaching in ophthalmology.

## Key findings

- The EyelearnMR group scored significantly better than the control group in technique assessments.
- Students using EyelearnMR achieved full marks more frequently than those in traditional teaching.
- User feedback showed positive perceptions of mixed reality's attractiveness, efficiency, and novelty.

## Abstract

Mixed reality has the potential to transform delivery of medical education. With tools such as HoloLens 2, educators can create immersive, interactive simulations that enable students to practice and engage with real-world scenarios in a controlled environment.

We postulated that a hybrid ophthalmology curriculum incorporating EyelearnMR (a simulation application) would be noninferior to traditional teaching. We compared learning outcomes and obtained user feedback.

This was a single-blind, cluster-randomized prospective study. Fourth-year medical students were organized into batches and then assigned to 2 groups: EyelearnMR and control arms. We used a quasi-randomized design with alternation allocation based on clinical grouping. The intervention group had an additional 2 hours of practice with the EyelearnMR devices. During the second week of their posting, a video assessment (5 scenarios with 17 multiple-choice questions) was conducted for both groups—mid-posting for the intervention group and at the end of the posting for the control group. The rationale for assessing the intervention group earlier, in addition to setting a higher bar for EyelearnMR, was to allow for the provision of outcomes showing noninferiority between both groups. In the event of noninferiority, we could demonstrate that EyelearnMR can replace some degree of traditional clinical teaching, even with a shorter total clinical exposure time. Students in the control group were allowed to experience the Eyelearn MR modules for 2 hours at the end of the posting. Both groups were asked to complete the User Experience Questionnaire.

This study was funded in February 2023, and recruitment took place from July 2023 to January 2024. A total of 54 students were recruited—24 (44.4%) in the control arm and 30 (55.6%) in the EyelearnMR arm. The EyelearnMR group performed significantly better than the control group (median scores of 16, IQR 15-17, and 15, IQR 14-15, respectively; P=.03; Mann-Whitney U test). A total of 100% (30/30) of the students in the EyelearnMR group scored full marks (3/3) for the technique portion, compared to 70.8% (17/24) of the students in the control group (P=.002). There was no statistically significant difference between the groups for the examination (P=.13) and pathology (P=.33) portions. This was despite the EyelearnMR group having a reduced clinical time of 7 days compared to 10 days in the control group. The User Experience Questionnaire showed positive evaluations for attractiveness (mean 1.413, SD 0.969), efficiency (mean 0.822, SD 1.068), dependability (mean 1.087, SD 0.801), stimulation (mean 1.577, SD 0.845), and novelty (mean 1.606, SD 0.967).

EyelearnMR with traditional teaching was noninferior to traditional teaching alone. It provided a comparable experience and supported learning objectives equally. It is an effective supplementary teaching tool in ophthalmic education and may confer additional learning benefits beyond a traditional clinical posting.

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12978906/full.md

---
Source: https://tomesphere.com/paper/PMC12978906